Eam Investors, LLC Terns Pharmaceuticals, Inc. Transaction History

Eam Investors, LLC

  • $581 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jul 12, 2023
BUY
$7.91 - $12.0 $818,700 - $1.24 Million
103,502 Added 419.31%
128,186 $1.52 Million
Q1 2023

May 12, 2023
SELL
$7.91 - $12.0 $818,700 - $1.24 Million
-103,502 Reduced 80.74%
24,684 $292,000
Q4 2022

Feb 14, 2023
BUY
$4.62 - $10.18 $592,219 - $1.3 Million
128,186 New
128,186 $1.3 Million

Others Institutions Holding TERN

# of Institutions
167
Shares Held
78.3M
Call Options Held
580K
Put Options Held
454K
View Full List

About Terns Pharmaceuticals, Inc.

TERN Quotes by TradingView
  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $216M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email